Novartis hopes that it will eventually become a multibillion dollar product, and analysts expect it to replace Diovan -- the company's current top-seller ...
Diovan, Diovan/HCT, Lotrel, Zelnorm, Tekturna, Famvir, Miacalcin, and Exforge are registered trademarks of Novartis AG Corporation or its affiliate. ...
The study compared the effect of a Diovan-based treatment (Diovan-HCT) with that of amlodipine on aortic pulse wave velocity (Ao-PWV – a measure of arterial ...